1.
|
Phase: Phase IV Type: Diagnostic Status: Active Age: 60 to 80 Sponsor: Other Protocol IDs: PROLOG, NCT00675168
|
|
2.
|
Phase: Phase IV Type: Supportive care Status: Approved-not yet active Age: 18 and over Sponsor: Other Protocol IDs: 2612-3681, NCT00724581
|
|
3.
|
Phase: Phase IV Type: Treatment Status: Active Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: simcere002, simcere0802, NCT00813332
|
|
4.
|
Phase: Phase IV Type: Treatment Status: Approved-not yet active Age: 18 Sponsor: Other Protocol IDs: P080204, IDRCB 2008-A01386-49, NCT00925444
|
|
5.
|
Phase: Phase IV Type: Treatment Status: Active Age: 18 to 75 Sponsor: Pharmaceutical / Industry Protocol IDs: SIM090801, NCT01028729
|
|
6.
|
Phase: Phase IV Type: Treatment Status: Approved-not yet active Age: 18 to 70 Sponsor: Pharmaceutical / Industry Protocol IDs: sim201002, NCT01211002
|
|
7.
|
Phase: Phase IV Type: Treatment Status: Active Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: ML25478, NCT01230710
|
|
8.
|
Phase: Phase IV Type: Treatment Status: Active Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: ML25575, NCT01287754
|
|
9.
|
Phase: Phase IV Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: RC08/29, NCT01320501
|
|
10.
|
Phase: Phase IV Type: Treatment Status: Active Age: 18 to 80 Sponsor: Other Protocol IDs: SHPH-11ZL113, NCT01336192
|
|
11.
|
Phase: Phase IV Type: Supportive care Status: Active Age: 18 to 75 Sponsor: Other Protocol IDs: 11021, NCT01381627
|
|
12.
|
Phase: Phase IV Type: Diagnostic Status: Active Age: 50 and over Sponsor: Other Protocol IDs: VMT-SPiN_01, NCT01389154
|
|
13.
|
Phase: Phase IV Type: Biomarker/Laboratory analysis, Treatment Status: Approved-not yet active Age: 18 and over Sponsor: Other Protocol IDs: SG 327/10, NCT01402089
|
|
14.
|
Phase: Phase IV Type: Treatment Status: Active Age: 18 to 75 Sponsor: Pharmaceutical / Industry Protocol IDs: BD-IC-IV01, NCT01465243
|
|
15.
|
Phase: Phase IV Type: Treatment Status: Active Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: ML27880, NCT01609543
|
|
16.
|
Phase: Phase IV Type: Treatment Status: Active Age: 70 to 80 Sponsor: Pharmaceutical / Industry Protocol IDs: BD-IC-IV20, NCT01646450
|
|
17.
|
Phase: Phase IV Type: Diagnostic Status: Active Age: 18 and over Sponsor: Other Protocol IDs: PAN-001, NCT01658280
|
|
18.
|
Phase: Phase IV Type: Treatment Status: Active Age: 18 to 70 Sponsor: Pharmaceutical / Industry Protocol IDs: BD-IC-IV08, NCT01665417
|
|
19.
|
Phase: Phase III, Phase II Type: Treatment Status: Active Age: 18 to 79 Sponsor: Pharmaceutical / Industry Protocol IDs: AMT/P2CA/001, LC003AURON2005, NCT00332280
|
|
20.
|
Phase: Phase III, Phase II Type: Supportive care, Treatment Status: Active Age: 17 to 75 Sponsor: Pharmaceutical / Industry Protocol IDs: PH-CP010, NCT00518869
|
|
21.
|
Phase: Phase III, Phase II Type: Treatment Status: Active Age: 18 to 70 Sponsor: Other Protocol IDs: IFCT-0703, Eudract : 2008-004897-41, NCT00775307
|
|
22.
|
Phase: Phase III, Phase II Type: Supportive care Status: Active Age: 20 to 75 Sponsor: Other Protocol IDs: INCAN/CC/330/09, CA171/CB/558/09, NCT01048970
|
|
23.
|
Phase: Phase III, Phase II Type: Biomarker/Laboratory analysis, Health services research, Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: CDR0000685322, EORTC-08092, EUDRACT-2010-018566-23, EU-21072, MAPPING, NCT01208064
|
|
24.
|
Phase: Phase III, Phase II Type: Supportive care Status: Active Age: 18 to 75 Sponsor: Other Protocol IDs: C-TONG1001, NCT01319669
|
|
25.
|
Phase: Phase III, Phase II Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: 9090-08, NCT01348126
|